文献速递产科母胎医学

肩难产与母婴复合不良结局

Shoulder dystocia and composite adverse outcomes for the maternal-neonatal dyad.
PubMed 文献 · Am J Obstet Gynecol MFM · 2021-03-20

本研究为安全分娩联盟队列的二次分析,纳入130008例34周及以上阴道分娩,其中肩难产2159例(1.7%)。肩难产组母体复合不良结局发生率为14.7%,高于非肩难产组的8.6%(aRR 1.71,95%CI 1.64-2.01);新生儿复合不良结局发生率分别为12.2%和2.4%(aRR 5.18,95%CI 4.60-5.84)。肩难产难以预测,其相关疾病负担同时影响母亲和新生儿。

要点

  • 肩难产与母体复合不良结局风险升高相关(aRR 1.71,95%CI 1.64-2.01)。
  • 肩难产与新生儿复合不良结局风险显著升高相关(aRR 5.18,95%CI 4.60-5.84)。
  • 基于母体特征或产时因素识别肩难产的AUC分别为0.66和0.67,预测能力有限。

核心结论

  • 肩难产虽不可预测,但其相关疾病负担同时影响母亲和新生儿,应关注同步降低母婴复合不良结局。

研究设计与样本

  • 安全分娩联盟观察性产科队列的二次分析,纳入19家医院2002-2008年34周及以上、有肩难产数据的阴道分娩。
  • 总队列228438例,130008例(59.6%)符合纳入标准,其中肩难产2159例(1.7%)。

主要发现

  • 肩难产组母体复合不良结局发生率为14.7%,非肩难产组为8.6%(aRR 1.71,95%CI 1.64-2.01)。
  • 肩难产组最常见母体不良结局为三度或四度会阴裂伤(aRR 2.82,95%CI 2.39-3.31)。
  • 肩难产组新生儿复合不良结局发生率为12.2%,非肩难产组为2.4%(aRR 5.18,95%CI 4.60-5.84)。
  • 肩难产组最常见新生儿不良结局为产伤(aRR 5.39,95%CI 4.71-6.17)。
  • 母体特征识别肩难产的AUC为0.66,产时因素为0.67。

关键数值与推荐

  • 母体复合不良结局包括三度或四度会阴裂伤、产后出血(阴道分娩>500 cc,剖宫产>1000 cc)、输血、绒毛膜羊膜炎、子宫内膜炎、血栓栓塞、入住ICU或母体死亡。
  • 新生儿复合不良结局包括5分钟Apgar评分<7、产伤、新生儿惊厥、缺氧缺血性脑病或新生儿死亡。

临床怎么用

  • 肩难产发生后应同时警惕母体产道裂伤和产后出血等并发症,并加强新生儿产伤评估。
  • 不应仅依赖母体特征或产时因素预测肩难产,其识别能力有限。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although the neonatal morbidity associated with shoulder dystocia are well known, the maternal morbidity caused by this obstetrical emergency is infrequently reported. OBJECTIVE: This study aimed to assess the composite adverse maternal and neonatal outcomes among vaginal deliveries (at 34 weeks or later) with and without shoulder dystocia. STUDY DESIGN: This is a secondary analysis of the Consortium of Safe Labor, an observational obstetrical cohort of all vaginal deliveries occurring at 19 hospitals (from 2002-2008) and for which data on the occurrence of shoulder dystocia were available. The composite adverse maternal outcome included third- or fourth-degree perineal laceration, postpartum hemorrhage (>500 cc blood loss for a vaginal delivery and >1000 cc blood loss for cesarean delivery), blood transfusion, chorioamnionitis, endometritis, thromboembolism, admission to intensive care unit, or maternal death. The composite adverse neonatal outcome included an Apgar score of <7 at 5 minutes, a birth injury, neonatal seizure, hypoxic ischemic encephalopathy, or neonatal death. A multivariable Poisson regression was used to estimate the adjusted relative risks with 95% confidence intervals. The area under the receiver operating characteristic curve was constructed to determine if clinical factors would identify shoulder dystocia. RESULTS: Of the 228,438 women in the overall cohort, 130,008 (59.6%) met the inclusion criteria, and among them, shoulder dystocia was documented in 2159 (1.7%) cases. The rate of composite maternal morbidity was significantly higher among deliveries with shoulder dystocia (14.7%) than without (8.6%; adjusted relative risk, 1.71; 95% confidence interval, 1.64-2.01). The most common maternal morbidity with shoulder dystocia was a third- or fourth-degree laceration (adjusted relative risk, 2.82; 95% confidence interval, 2.39-3.31). The risk of composite neonatal morbidity with shoulder dystocia (12.2%) was also significantly higher than without shoulder dystocia (2.4%) (adjusted relative risk, 5.18; 95% confidence interval, 4.60-5.84). The most common neonatal morbidity was birth injury (adjusted relative risk, 5.39; 95% confidence interval, 4.71-6.17). The area under the curve for maternal characteristics to identify shoulder dystocia was 0.66 and it was 0.67 for intrapartum factors. CONCLUSION: Although shoulder dystocia is unpredictable, the associated morbidity affects both mothers and newborns. The focus should be on concurrently averting the composite morbidity for the maternal-neonatal dyad with shoulder dystocia.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Mendez-Figueroa H, Hoffman MK, Grantz KL, et al. Shoulder dystocia and composite adverse outcomes for the maternal-neonatal dyad. Am J Obstet Gynecol MFM. 2021. PMID: 33757935. doi:10.1016/j.ajogmf.2021.100359

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。